
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Medidata takes step to offer the most complete data and analytics capabilities in clinical research, with new predictive analytics and benchmarking in Edge Study Feasibility and MEDS Perform. Both were built on the MEDS data backbone which allows sponsors/CROs to collaborate in a "give-to-get" model powering analytics. These capabilities are enabiling teams to create smarter treatments.
Read the full release






